483
Apitoria Pharma Private LimitedApitoria Pharma Private Limited – FDA 483, May 19, 2023
Record Details
An FDA inspection of Aurobindo Pharma Limited, Unit XIV, an API manufacturer in Anakapalli District, India, revealed significant deficiencies. Observations included inadequate manufacturing equipment cleaning and storage, improper resealing of API product drums, and raw materials stored outside specified conditions. Additionally, laboratory controls were found lacking, with issues in instrument verification, secondary standard qualification, and chromatographic test precision.
View Company Profile
ID · 38af609e-8879-4c0f-80c9-c894629e447d
Other documents for Apitoria Pharma Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.